Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
INSULET CORP
Report date April 28, 2025 · Filed April 30, 2025
Section 16 reporting ended · disclosed 2025-04-30. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 61,247 |
Reported balance
After 2025-04-28 transaction · row 1
1 source rowRow 1 · 2025-04-28 · Tax withholding · Disposed 3,587 · Balance 61,247 F1: This transaction represents the withholding of shares received upon the vesting of restricted stock units to cover the associated tax obligations. |
Filing footnotes · ownership attribution and instrument terms
F1: This transaction represents the withholding of shares received upon the vesting of restricted stock units to cover the associated tax obligations.
RESMED INC
Report date June 30, 2022 · Filed August 18, 2022
Section 16 reporting ended · disclosed 2022-08-18. Current position is not established by this disclosure.
No balance rows disclosed in this filing.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 01, 2020 Filed Jun 2, 2020 23:46 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 1,200 | $160.13 | $192,156.00 |
DisclosureSEC source: 0001127602-20-018533 · form4.xml · nonDerivative · entry 1 Hollingshead James · CIK 0001570610 · President, Sleep Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,274 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. F2 · balance_after: Includes 108.59 shares of ResMed stock purchased on April 30, 2020, through the ResMed Employee Stock Purchase Plan. Read SEC document |
| May 28, 2020 Filed Jun 1, 2020 20:52 UTC | INSULET CORP PODD · Entity 3516 | GrantCommon Stock | 1,029 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-018244 · form4.xml · nonDerivative · entry 1 Hollingshead James · CIK 0001570610 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,062 F1 · shares: Annual equity award in the form of restricted stock units ("RSUs"). RSUs vest in full on April 30, 2021 and are settled in shares of common stock on a one-for-one basis. Read SEC document |
| May 01, 2020 Filed May 5, 2020 16:44 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 1,200 | $164.00 | $196,800.00 |
DisclosureSEC source: 0001127602-20-015375 · form4.xml · nonDerivative · entry 1 Hollingshead James · CIK 0001570610 · President, Sleep Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,365 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| April 02, 2020 Filed Apr 3, 2020 20:25 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 1,200 | $150.00 | $180,000.00 |
DisclosureSEC source: 0001127602-20-013133 · form4.xml · nonDerivative · entry 1 Hollingshead James · CIK 0001570610 · President, Sleep Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,565 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| March 02, 2020 Filed Mar 3, 2020 21:15 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 1,200 | $160.50 | $192,600.00 |
DisclosureSEC source: 0001127602-20-008964 · form4.xml · nonDerivative · entry 1 Hollingshead James · CIK 0001570610 · President, Sleep Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,765 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| February 20, 2020 Filed Feb 20, 2020 23:54 UTC | RESMED INC RMD · Entity 2692 | Tax withholdingResMed Common Stock | 9,105 | $176.00 | $1,602,480.00 |
DisclosureSEC source: 0001127602-20-006757 · form4.xml · nonDerivative · entry 3 Hollingshead James · CIK 0001570610 · President, Sleep Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,965 F1 · kind: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 2/16/2017. Read SEC document |
| February 20, 2020 Filed Feb 20, 2020 23:54 UTC | RESMED INC RMD · Entity 2692 | GrantResMed Common Stock | 15,370 | $176.00 | $2,705,120.00 |
DisclosureSEC source: 0001127602-20-006757 · form4.xml · nonDerivative · entry 2 Hollingshead James · CIK 0001570610 · President, Sleep Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,070 F2 · kind: Represents performance-based restricted stock units granted on February 16, 2017. The shares were earned on February 20, 2020, when the compensation committee certified that the performance metrics were met. Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 23:54 UTC | RESMED INC RMD · Entity 2692 | Tax withholdingResMed Common Stock | 1,274 | $174.80 | $222,695.20 |
DisclosureSEC source: 0001127602-20-006757 · form4.xml · nonDerivative · entry 1 Hollingshead James · CIK 0001570610 · President, Sleep Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,700 F1 · kind: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 2/16/2017. Read SEC document |
| February 03, 2020 Filed Feb 5, 2020 18:22 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 1,200 | $159.46 | $191,352.00 |
DisclosureSEC source: 0001127602-20-003705 · form4.xml · nonDerivative · entry 1 Hollingshead James · CIK 0001570610 · President, Sleep Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,974 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 17:46 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 1,200 | $155.40 | $186,480.00 |
DisclosureSEC source: 0001127602-20-001015 · form4.xml · nonDerivative · entry 1 Hollingshead James · CIK 0001570610 · President, Sleep Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,174 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| December 02, 2019 Filed Dec 5, 2019 00:45 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock Options · Derivative | 800 | $0.00 Strike: $58.24 | $0.00 |
DisclosureSEC source: 0001127602-19-034304 · form4.xml · derivative · entry 4 Hollingshead James · CIK 0001570610 · President, Sleep Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: ResMed Common Stock · 800 shares Expires 2022-11-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. F2 · derivative.exercise_date: Represents date options first became exercisable. Options vest 1/3 per year. Read SEC document |
| December 02, 2019 Filed Dec 5, 2019 00:45 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 800 | $149.89 | $119,912.00 |
DisclosureSEC source: 0001127602-19-034304 · form4.xml · nonDerivative · entry 3 Hollingshead James · CIK 0001570610 · President, Sleep Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,374 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| December 02, 2019 Filed Dec 5, 2019 00:45 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 800 | $149.89 | $119,912.00 |
DisclosureSEC source: 0001127602-19-034304 · form4.xml · nonDerivative · entry 2 Hollingshead James · CIK 0001570610 · President, Sleep Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,174 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| December 02, 2019 Filed Dec 5, 2019 00:45 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock | 800 | $58.24 | $46,592.00 |
DisclosureSEC source: 0001127602-19-034304 · form4.xml · nonDerivative · entry 1 Hollingshead James · CIK 0001570610 · President, Sleep Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,974 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| November 21, 2019 Filed Nov 22, 2019 21:02 UTC | RESMED INC RMD · Entity 2692 | Tax withholdingResMed Common Stock | 18,633 | $146.34 | $2,726,753.22 |
DisclosureSEC source: 0001127602-19-033557 · form4.xml · nonDerivative · entry 2 Hollingshead James · CIK 0001570610 · President, Sleep Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,174 F2 · kind: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/16/2016. Read SEC document |
| November 21, 2019 Filed Nov 22, 2019 21:02 UTC | RESMED INC RMD · Entity 2692 | GrantResMed Common Stock | 31,458 | $146.34 | $4,603,563.72 |
DisclosureSEC source: 0001127602-19-033557 · form4.xml · nonDerivative · entry 1 Hollingshead James · CIK 0001570610 · President, Sleep Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,807 F1 · kind: Represents performance-based restricted stock units granted on November 16, 2016. The shares were earned on November 21, 2019, when the compensation committee certified that the performance metrics were met. Read SEC document |
| November 15, 2019 Filed Nov 18, 2019 23:50 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock Options · Derivative | 20,038 | $0.00 Strike: $58.24 | $0.00 |
DisclosureSEC source: 0001127602-19-033096 · form4.xml · derivative · entry 5 Hollingshead James · CIK 0001570610 · President, Sleep Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 800 Underlying: ResMed Commmon Stock · 20,038 shares Expires 2022-11-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Represents date options first became exercisable. Options vest 1/3 per year. Read SEC document |
| November 15, 2019 Filed Nov 18, 2019 23:50 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock Options · Derivative | 1,717 | $0.00 Strike: $58.24 | $0.00 |
DisclosureSEC source: 0001127602-19-033096 · form4.xml · derivative · entry 4 Hollingshead James · CIK 0001570610 · President, Sleep Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,838 Underlying: ResMed Commmon Stock · 1,717 shares Expires 2022-11-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Represents date options first became exercisable. Options vest 1/3 per year. Read SEC document |
| November 15, 2019 Filed Nov 18, 2019 23:50 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 20,038 | $146.35 | $2,932,561.30 |
DisclosureSEC source: 0001127602-19-033096 · form4.xml · nonDerivative · entry 3 Hollingshead James · CIK 0001570610 · President, Sleep Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,349 F1 · price: This transaction was executed in multiple trades at prices ranging from $146.07 to 146.80. The price reported above reflects the weighted average sale price. Read SEC document |
| November 15, 2019 Filed Nov 18, 2019 23:50 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock | 20,038 | $58.24 | $1,167,013.12 |
DisclosureSEC source: 0001127602-19-033096 · form4.xml · nonDerivative · entry 2 Hollingshead James · CIK 0001570610 · President, Sleep Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,387 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 15, 2019 Filed Nov 18, 2019 23:50 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock | 1,717 | $58.24 | $99,998.08 |
DisclosureSEC source: 0001127602-19-033096 · form4.xml · nonDerivative · entry 1 Hollingshead James · CIK 0001570610 · President, Sleep Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,349 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 11, 2019 Filed Nov 14, 2019 01:08 UTC | RESMED INC RMD · Entity 2692 | Tax withholdingResMed Common Stock | 2,547 | $143.88 | $366,462.36 |
DisclosureSEC source: 0001127602-19-032673 · form4.xml · nonDerivative · entry 3 Hollingshead James · CIK 0001570610 · President, Sleep Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,632 F4 · kind: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/16/2016. Read SEC document |
| November 11, 2019 Filed Nov 14, 2019 01:08 UTC | RESMED INC RMD · Entity 2692 | Tax withholdingResMed Common Stock | 1,804 | $143.88 | $259,559.52 |
DisclosureSEC source: 0001127602-19-032673 · form4.xml · nonDerivative · entry 2 Hollingshead James · CIK 0001570610 · President, Sleep Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,179 F3 · kind: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/14/2018. Read SEC document |
| November 11, 2019 Filed Nov 14, 2019 01:08 UTC | RESMED INC RMD · Entity 2692 | Tax withholdingResMed Common Stock | 2,134 | $143.88 | $307,039.92 |
DisclosureSEC source: 0001127602-19-032673 · form4.xml · nonDerivative · entry 1 Hollingshead James · CIK 0001570610 · President, Sleep Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,983 F1 · kind: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/16/2017. F2 · balance_after: Includes 70.936 shares of ResMed stock purchased on October 31, 2019, through the ResMed Employee Stock Purchase Plan. Read SEC document |
| November 01, 2019 Filed Nov 5, 2019 20:23 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock Options · Derivative | 800 | $0.00 Strike: $58.24 | $0.00 |
DisclosureSEC source: 0001127602-19-031861 · form4.xml · derivative · entry 4 Hollingshead James · CIK 0001570610 · President, Sleep Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,555 Underlying: ResMed Commmon Stock · 800 shares Expires 2022-11-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| November 01, 2019 Filed Nov 5, 2019 20:23 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 800 | $148.92 | $119,136.00 |
DisclosureSEC source: 0001127602-19-031861 · form4.xml · nonDerivative · entry 3 Hollingshead James · CIK 0001570610 · President, Sleep Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,046 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| November 01, 2019 Filed Nov 5, 2019 20:23 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 800 | $148.92 | $119,136.00 |
DisclosureSEC source: 0001127602-19-031861 · form4.xml · nonDerivative · entry 2 Hollingshead James · CIK 0001570610 · President, Sleep Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,846 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| November 01, 2019 Filed Nov 5, 2019 20:23 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock | 800 | $58.24 | $46,592.00 |
DisclosureSEC source: 0001127602-19-031861 · form4.xml · nonDerivative · entry 1 Hollingshead James · CIK 0001570610 · President, Sleep Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,646 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| October 24, 2019 Filed Oct 25, 2019 20:07 UTC | RESMED INC RMD · Entity 2692 | GrantResMed Common Stock | 2,545 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-031068 · form4.xml · nonDerivative · entry 1 Hollingshead James · CIK 0001570610 · President, Sleep Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,846 F1 · shares: Represents performance-based restricted stock units granted on November 14, 2018. The shares were earned on October 24, 2019, when the compensation committee certified that the performance metrics were met for this portion of the grant. The earned units remain subject to time-vesting requirements, and are scheduled to vest on the three-year anniversary of the grant, assuming continued service through the vesting date. Read SEC document |
| October 01, 2019 Filed Oct 2, 2019 17:46 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock Options · Derivative | 800 | $0.00 Strike: $58.24 | $0.00 |
DisclosureSEC source: 0001127602-19-029606 · form4.xml · derivative · entry 4 Hollingshead James · CIK 0001570610 · President, Sleep Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,355 Underlying: ResMed Commmon Stock · 800 shares Expires 2022-11-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. F2 · derivative.exercise_date: Represents date options first became exercisable. Options vest 1/3 per year. Read SEC document |
| October 01, 2019 Filed Oct 2, 2019 17:46 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 800 | $135.13 | $108,104.00 |
DisclosureSEC source: 0001127602-19-029606 · form4.xml · nonDerivative · entry 3 Hollingshead James · CIK 0001570610 · President, Sleep Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,301 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| October 01, 2019 Filed Oct 2, 2019 17:46 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 800 | $135.13 | $108,104.00 |
DisclosureSEC source: 0001127602-19-029606 · form4.xml · nonDerivative · entry 2 Hollingshead James · CIK 0001570610 · President, Sleep Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,101 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| October 01, 2019 Filed Oct 2, 2019 17:46 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock | 800 | $58.24 | $46,592.00 |
DisclosureSEC source: 0001127602-19-029606 · form4.xml · nonDerivative · entry 1 Hollingshead James · CIK 0001570610 · President, Sleep Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,901 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| September 03, 2019 Filed Sep 4, 2019 21:16 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock Options · Derivative | 800 | $0.00 Strike: $58.24 | $0.00 |
DisclosureSEC source: 0001127602-19-027909 · form4.xml · derivative · entry 4 Hollingshead James · CIK 0001570610 · President, Sleep Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,155 Underlying: ResMed Commmon Stock · 800 shares Expires 2022-11-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. F2 · derivative.exercise_date: Represents date options first became exercisable. Options vest 1/3 per year. Read SEC document |
| September 03, 2019 Filed Sep 4, 2019 21:16 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 800 | $138.11 | $110,488.00 |
DisclosureSEC source: 0001127602-19-027909 · form4.xml · nonDerivative · entry 3 Hollingshead James · CIK 0001570610 · President, Sleep Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,102 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| September 03, 2019 Filed Sep 4, 2019 21:16 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 800 | $138.11 | $110,488.00 |
DisclosureSEC source: 0001127602-19-027909 · form4.xml · nonDerivative · entry 2 Hollingshead James · CIK 0001570610 · President, Sleep Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,902 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| September 03, 2019 Filed Sep 4, 2019 21:16 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock | 800 | $58.24 | $46,592.00 |
DisclosureSEC source: 0001127602-19-027909 · form4.xml · nonDerivative · entry 1 Hollingshead James · CIK 0001570610 · President, Sleep Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,702 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| August 14, 2019 Filed Aug 15, 2019 01:08 UTC | RESMED INC RMD · Entity 2692 | GrantResMed Common Stock | 10,279 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-026650 · form4.xml · nonDerivative · entry 1 Hollingshead James · CIK 0001570610 · President, Sleep Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,902 F1 · shares: Represents performance-based restricted stock units granted on November 14, 2018. The shares were earned on August 14, 2019, when the compensation committee certified that the performance metrics were met. Stock units vest 1/3 each year on the anniversary of the grant. Read SEC document |
| August 01, 2019 Filed Aug 2, 2019 16:57 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock Options · Derivative | 800 | $0.00 Strike: $58.24 | $0.00 |
DisclosureSEC source: 0001127602-19-025789 · form4.xml · derivative · entry 4 Hollingshead James · CIK 0001570610 · President, Sleep Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,955 Underlying: ResMed Commmon Stock · 800 shares Expires 2022-11-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Represents date options first became exercisable. Options vest 1/3 per year. Read SEC document |
| August 01, 2019 Filed Aug 2, 2019 16:57 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 800 | $129.50 | $103,600.00 |
DisclosureSEC source: 0001127602-19-025789 · form4.xml · nonDerivative · entry 3 Hollingshead James · CIK 0001570610 · President, Sleep Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,623 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| August 01, 2019 Filed Aug 2, 2019 16:57 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 800 | $129.50 | $103,600.00 |
DisclosureSEC source: 0001127602-19-025789 · form4.xml · nonDerivative · entry 2 Hollingshead James · CIK 0001570610 · President, Sleep Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,423 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| August 01, 2019 Filed Aug 2, 2019 16:57 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock | 800 | $58.24 | $46,592.00 |
DisclosureSEC source: 0001127602-19-025789 · form4.xml · nonDerivative · entry 1 Hollingshead James · CIK 0001570610 · President, Sleep Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,223 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| July 31, 2019 Filed Aug 1, 2019 21:31 UTC | INSULET CORP PODD · Entity 3516 | GrantCommon Stock | 2,033 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-025690 · form4.xml · nonDerivative · entry 1 Hollingshead James · CIK 0001570610 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,033 F1 · shares: Initial equity award in the form of restricted stock units ("RSUs"). RSUs vest 50% on the first anniversary of the date of grant and 25% on each of the second and third anniversaries of the date of grant. The RSUs are settled in shares of common stock on a one-for-one basis. Read SEC document |
| July 01, 2019 Filed Jul 2, 2019 21:05 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock Options · Derivative | 800 | $0.00 Strike: $58.24 | $0.00 |
DisclosureSEC source: 0001127602-19-023656 · form4.xml · derivative · entry 4 Hollingshead James · CIK 0001570610 · President, Sleep Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,038 Underlying: ResMed Commmon Stock · 800 shares Expires 2022-11-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| July 01, 2019 Filed Jul 2, 2019 21:05 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 800 | $123.17 | $98,536.00 |
DisclosureSEC source: 0001127602-19-023656 · form4.xml · nonDerivative · entry 3 Hollingshead James · CIK 0001570610 · President, Sleep Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,423 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| July 01, 2019 Filed Jul 2, 2019 21:05 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock | 800 | $58.24 | $46,592.00 |
DisclosureSEC source: 0001127602-19-023656 · form4.xml · nonDerivative · entry 2 Hollingshead James · CIK 0001570610 · President, Sleep Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,223 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| July 01, 2019 Filed Jul 2, 2019 21:05 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 800 | $123.17 | $98,536.00 |
DisclosureSEC source: 0001127602-19-023656 · form4.xml · nonDerivative · entry 1 Hollingshead James · CIK 0001570610 · President, Sleep Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,023 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| June 03, 2019 Filed Jun 4, 2019 20:18 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock Options · Derivative | 800 | $0.00 Strike: $58.24 | $0.00 |
DisclosureSEC source: 0001127602-19-020711 · form4.xml · derivative · entry 4 Hollingshead James · CIK 0001570610 · President, Sleep Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,838 Underlying: ResMed Commmon Stock · 800 shares Expires 2022-11-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. F2 · derivative.exercise_date: Represents date options first became exercisable. Options vest 1/3 per year. Read SEC document |
| June 03, 2019 Filed Jun 4, 2019 20:18 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 800 | $114.01 | $91,208.00 |
DisclosureSEC source: 0001127602-19-020711 · form4.xml · nonDerivative · entry 3 Hollingshead James · CIK 0001570610 · President, Sleep Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,223 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| June 03, 2019 Filed Jun 4, 2019 20:18 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 800 | $114.01 | $91,208.00 |
DisclosureSEC source: 0001127602-19-020711 · form4.xml · nonDerivative · entry 2 Hollingshead James · CIK 0001570610 · President, Sleep Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,023 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.